Business Card for Steve Mansfield:


Business Operations
 Boston, MA area
Email Avail: 3 Day Free Trial


Vertex Pharmaceuticals Inc.
Boston, MA 02210
Tel: (617) 341-6100

Last updated on 2017-11-20

About Steve Mansfield:

Steve Mansfield works as an Business Operations for Vertex Pharmaceuticals at Boston, MA. The company's webpage is http://www.vrtx.com. For email, phone number and executive profiles for Business Operations and other executives of Vertex Pharmaceuticals at Boston, MA, check Vertex Pharmaceuticals at Joesdata.com. Not the Steve Mansfield you are looking for? Do a quick search in our website and find other people named Steve Mansfield.
Steve Mansfield's Work History:
No information available..

Steve Mansfield's Education:
No information available..

Steve Mansfield's Co-workers:
As of July 5, 2022, Steve Mansfield has 302 co-workers under the company name Vertex Pharmaceuticals at Joesdata.com.

About Vertex Pharmaceuticals:

Vertex Pharmaceuticals is located at Vertex Pharmaceuticals Inc., Boston, MA 02210. It has over 10K employees. Its revenue is over $1B.

Company News:
2018-09-11 18:54:16
Vertex to Present at the Morgan Stanley Healthcare Conference on September 14
2018-09-11 17:30:54
Vertex to Present at the Morgan Stanley Healthcare Conference on September 14
2018-09-10 17:30:38
Vertex Appoints Katharine Jensen as Head of Corporate Social Responsibility
2018-09-10 16:32:58
Vertex Appoints Katharine Jensen as Head of Corporate Social Responsibility
2018-09-06 19:18:42
Vertex Completes Enrollment of Two Phase 3 Studies of VX-659 in Triple Combination with Tezacaftor and Ivacaftor for the Treatment of Cystic Fibrosis
2018-09-06 17:30:41
Vertex Completes Enrollment of Two Phase 3 Studies of VX-659 in Triple Combination with Tezacaftor and Ivacaftor for the Treatment of Cystic Fibrosis
2018-09-03 17:30:38
Vertex Announces Reimbursement Agreement in Australia for ORKAMBI (lumacaftor/ivacaftor) for People with Cystic Fibrosis Ages Six Years and Older with Two Copies of the F508del Mutation
2018-09-03 17:06:32
Vertex Announces Reimbursement Agreement in Australia for ORKAMBI (lumacaftor/ivacaftor) for People with Cystic Fibrosis Ages Six Years and Older with Two Copies of the F508del Mutation
2018-08-30 17:30:48
Vertex and Genomics plc Establish Collaboration to Use Human Genetics and Data Science to Advance Discovery of Precision Medicines
2018-08-30 17:06:23
Vertex and Genomics plc Establish Collaboration to Use Human Genetics and Data Science to Advance Discovery of Precision Medicines

People in the same industry: